emergency-sign-at-hospital-300x201-7290191New York’s hospitals are lagging the nation in the push to reduce readmission rates, newly released federal data show.

Under a provision of the Affordable Care Act, the federal government docks Medicare payments to hospitals that have too many patients bounce back within 30 days of discharge.

High readmission rates are seen as an indicator of flawed care management and a driver of excess healthcare spending.

Ninety-three percent of the state’s hospitals face a penalty in the year ahead, according to the data, according to a summary table published by Kaiser Health News. That’s the sixth-highest share in the nation, 13 points above the average for all states.

The average penalty for New York hospitals, which is just under 1 percent of Medicare fees, is the fifth highest. The average for hospitals nationwide was about 0.6 percent.

Three New York hospitals – Arnot Ogden in Elmira, Auburn Memorial in Auburn, and St. John’s Episcopal in Far Rockaway – face the highest possible penalty of 3 percent.

Ten achieved low enough readmission rates to avoid any penalty: Albany Memorial, Burdett Care Center in Troy, Cobleskill Regional, HealthAlliance Mary’s Avenue Campus in Kingston, Helen Hayes in West Haverstraw, Hospital for Special Surgery in Manhattan, Jones Memorial in Wellsville, Monroe Community in Rochester, New York Eye and Ear Infirmary in Manhattan, Sunnyview in Schenectady and Westfield Memorial.

Another 21 New York hospitals specializing in the care of veterans, children, psychiatric patients, or cancer patients were exempt from the program.

A study published last year by the federal Centers for Medicare & Medicaid Services showed that readmission rates nationwide declined by 8 percent in the first five years of the penalty program.

The rate among New York hospitals declined by almost 11 percent, but remained the seventh-highest among states as of 2015.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More
Text here